Novo Nordisk A/S

(NVO) Trade

By |

Profile

With almost 50% market share by volume of the global insulin market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, as well as oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 20% of revenue) that specializes in protein therapies for hemophilia and other disorders.

Contact Information

Website: www.novonordisk.com
Email: phak@novonordisk.com
Main Phone: +45 44448888
Address: Novo Alle
City / Town: Bagsvaerd
Country: DNK
Postal Code: 2880

Issuer Information

Exchange: NYE
CEO: Lars Fruergaard Jorgensen
Employees: 43007
NAICS: Pharmaceutical P


Gathering Data... Please wait

Profile

With almost 50% market share by volume of the global insulin market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, as well as oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 20% of revenue) that specializes in protein therapies for hemophilia and other disorders.

Contact Information

Website: www.novonordisk.com
Email: phak@novonordisk.com
Main Phone: +45 44448888
Address: Novo Alle
City / Town: Bagsvaerd
Country: DNK
Postal Code: 2880

Issuer Information

Exchange: NYE
CEO: Lars Fruergaard Jorgensen
Employees: 43007
NAICS: Pharmaceutical P
$ 47.99 $ -0.29 (-0.60%)
Last Price 47.99 Change $ -0.29 Change % -0.60 Tick N/A
Bid N/A Bid Size 0.00 Ask N/A Ask Size 0.00
Open 47.88 High 48.17 Low 47.58 Prev Close 48.28
Last Trade Volume 2.2 mi 52 Wk Hi 52.83 52 Wk Low 41.23
Market Cap 113.8 bi Ex-Div Date Div Rate 1.55 Yield 3.2380
Shares 2,371,868,457.00 EPS (TTM) 2.42 PE Ratio 19.70 Exchange NYSE
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 60.4 60.4 60.4 60.4
Low Target Price Estimate 60.4 60.4 60.4 60.4
Mean Target Price Estimate 60.4 60.4 60.4 60.4
Standard Deviation 0 0 0 0
Date of Most Recent Estimate 05/29/18 05/29/18 05/03/18 05/29/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 1 1 1 1
Moderate Buy 1 1 1 1
Hold 2 2 2 3
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 2.13 2.13 2.13 2.3